Article Per Year (5 Year)
p-Index From 2021 - 2026
4.08
P-Index
This Author published in this journals
All Journal Jurnal Berkala Epidemiologi Folia Medica Indonesiana Syntax Literate: Jurnal Ilmiah Indonesia Indonesian Journal of Rheumatology Care : Jurnal Ilmiah Ilmu Kesehatan Biomolecular and Health Science Journal JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga Journal of the Indonesian Medical Association : Majalah Kedokteran Indonesia Majalah Biomorfologi (Biomorphology Journal) CURRENT INTERNAL MEDICINE RESEARCH AND PRACTICE SURABAYA JOURNAL Indian Journal of Forensic Medicine & Toxicology Jurnal Rumpun Ilmu Kesehatan Jurnal Penyakit Dalam Indonesia Indonesian Journal of Endocrinology Metabolism and Diabetes (InaJEMD) JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Jurnal Ilmu Kedokteran dan Kesehatan Indonesia
Hermina Novida, Hermina
Division Of Endocrinology, Department Of Internal Medicine, Faculty Of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya
Humanities Biochemistry, Genetics & Molecular Biology Education Environmental Science Health Professions Immunology & microbiology Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Neuroscience Nursing Public Health Social Sciences Other

Published : 33 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 33 Documents
Search

 1   2   3   4 
Faktor Risiko Kematian Pada Pasien Diabetes Melitus dan Penyakit Jantung: Systematic Review Cindy Muazizah; Hermina Novida
Jurnal Ilmu Kedokteran dan Kesehatan Indonesia Vol. 4 No. 2 (2024): Juli: Jurnal Ilmu Kedokteran dan Kesehatan Indonesia
Publisher : Pusat Riset dan Inovasi Nasional

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55606/jikki.v4i2.3908

Abstract

Word Health Organization defines a cause of death as an illness, disease or injury that causes or contributes to death. Diabetes mellitus is a major comorbidity and cardiac arrest is the highest cause of death. Cardiovascular disease is more common in men with an average age of 57 years. There are many types of cardiovascular disease, but the most common and well-known are coronary heart disease and stroke. Basic Health (Riskesdas) in 2018 reported that the incidence of heart and blood vessel disease is increasing from year to year. The main factor in heart disease is uncontrolled blood sugar, while the most common macrovascular complication of diabetes mellitus is coronary heart disease. Causative factors The prevalence of type 2 diabetes mellitus is caused by the interaction between gene susceptibility factors and environmental exposure as follows Genetics and Environment The occurrence of coronary heart disease is closely related to the presence of disorders affecting the blood vessels called atherosclerosis. This research uses a systematic review based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). with inclusion and exclusioncriteria, the risk of cardiovascular death and myocardial infarction was higher with increasing values ​​of lysis time and maximum turbidity.
PROFIL PENDERITA DIABETES MELITUS DENGAN HIPOGLIKEMIA DI INSTALASI RAWAT INAP PENYAKIT DALAM RSUD DR. SOETOMO PERIODE 2017 Putri, Anandia Nafisah; Novida, Hermina; Wardhani, Puspa
Care : Jurnal Ilmiah Ilmu Kesehatan Vol 9, No 1 (2021): EDITION MARCH 2021
Publisher : Universitas Tribhuwana Tunggadewi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33366/jc.v9i1.1384

Abstract

Diabetes mellitus can cause hypoglycemia that caused by various factors. This study aimed to determine the profile of general characteristics and metabolic parameters of diabetics with hypoglycemia at the Internal Medicine Inpatient Installation of Dr. Soetomo Hospital on 2017 period. This study was a cross-sectional descriptive study using medical record data of type 1 and type 2 diabetic patients. The total number of hypoglycemic patients in type 2 diabetes was 79 patients. Most patients were in the 50-70 years age group (72.1%), female (60.8%), diabetes duration >5 years (40.5%), and consumsing sulfonylurea (27.8%). Most patients had eGFR value of
Perbedaan Kontrol Glikemik Terapi Metformin Dibandingkan Glimepiride pada Pasien Diabetes Melitus Tipe 2 di RSI Jemursari Surabaya pada Tahun 2018 Nariswari, Rachma Putri; Prabowo, Gwenny Ichsan; Novida, Hermina; Hasanatuludhhiyah, Nurina
Majalah Kedokteran Indonesia Vol 71 No 1 (2021): Journal of The Indonesian Medical Association - Majalah Kedokteran Indonesia, Vo
Publisher : PENGURUS BESAR IKATAN DOKTER INDONESIA (PB IDI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47830/jinma-vol.71.1-2021-281

Abstract

Introduction: Type 2 diabetes mellitus is caused by decreased tissue sensitivity to insulin. The prevalence of diabetes in the world has almost doubled since 1980, from 4.7% to 8.5% in adult population. Early diagnosis and treatment aimed at normalizing glycemic control are very important. The objective of this study was to evaluate and compare glycemic control of metformin and glimepiride in monotherapy of type 2 diabetes mellitus patients at Islamic Jemursari Hospital Surabaya. Method: This was a retrospective observational study using secondary data (medical record), include glycemic control (RPG) before and two months after receiving therapy of outpatients’ type 2 diabetes mellitus with metformin or glimepiride therapy in 2018. 96 samples were found that fit the inclusion criteria. The data were analyzed by Mann-Whitney test. Result: Most patients were female, aged 50-69 years old, and dosage of metformin therapy 1500 mg/day or glimepiride therapy 2 mg/day. There was no significant difference (p greater than 0.05) of glycemic control (RPG) of metformin compared to glimepiride therapies in type 2 diabetes mellitus patients at Islamic Jemursari Hospital Surabaya in 2018. Conclusion: Metformin and glimepiride were not significantly different in glycemic control (RPG). There were patients with RPG greater than 200 mg/dl after two months of metformin or glimepiride therapy.
Co-Authors Agung Dwi Wahyu Widodo AGUNG PRANOTO Agung Pranoto Ahmed Eliaan Shaker Abuajwa Alviano Satria Wibawa Andriana, RA Meisy Andrianto Andriati Andriati Ari Sutjahjo, Ari Arisvia Sukma Hariftyani Aryati Aryati Askandar Tjokroprawiro Asmarawati, Tri Pudy Awalia Awalia Awalia, Awalia Betty Agustina Tambunan Bodová, Klára Caesar Lagaliggo Givani Cindy Muazizah Deasy Ardiany Desak Gde Ushadi Bulan Dewata Dian Galuh Maharani Dian Ristanti Dicky Febrianto Drestha Pratita Windriya Fajar Setiyawan Fauzi, Machfud Febrian Daru Setiawan Gatot Soegiarto Hanik Badriyah Hidayati,* Mohammad Hasan Machfoed,* Kuntoro,** Soetojo,*** Budi Santoso,**** Suroto,***** Budi Utomo****** HERAWATI, LILIK Hidayat, Nadia Humairah, Ira I'tishom, Reny Isnin Anang Marhana Jihadna Prima Santika Ruslan Musanip Jongky H Prajitno, Jongky H Jongky Hendro Prajitno kholidatul husna Lutfi, Delfitri Martino Handoyo Mouli Edward Muhammad Faizi Muhammad Zaim Abbas Hisyam Nadia Hidayat Nariswari, Rachma Putri Novianto, Rifky Alif Nurina Hasanatuludhhiyah Nurul Bashirah Aminy Pawana, I Putu Alit Prabowo, Gwenny Ichsan Purwati Putri, Anandia Nafisah Qurnianingsih, Ema Ramadhani, Rizqi Nabila Rejeki, Purwo Sri Ristanti, Dian Rizki Adrian Hakim Robert Dwitama Adiwinoto Sari, Gadis Meinar Sembiring, Yan Efrata Shafiero Muhammad Elsya Putera Soebroto, Heroe Soelistijo, Soebagijo Adi Soenarnatalina Melaniani Sony Wibisono Sony Wibisono Sri Purwaningsih Stepanus Massora Syahraya, Indira Troy Fonda Wardani, Erlisa Pramodya Wardhani, Puspa William, Andrew